Effect of different challenge doses after repeated citalopram treatment on extracellular serotonin level in the medial prefrontal cortex: In vivo microdialysis study

Psychiatry and Clinical Neurosciences

Volumn 62, Issue 5, 2008, Pages 568-574

  Muraki, Ihoko ^a   Inoue, Takeshi ^a   Hashimoto, Shinji ^a   Izumi, Takeshi ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Citalopram; In vivo brain microdialysis; Medial prefrontal cortex; Serotonin; SSRI

Indexed keywords

CITALOPRAM; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CELL LEVEL; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; IN VIVO STUDY; LOW DRUG DOSE; MALE; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; RAT; REPEATED DRUG DOSE;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; AROUSAL; CITALOPRAM; CONDITIONING, CLASSICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR FLUID; INJECTIONS, SUBCUTANEOUS; MALE; MICRODIALYSIS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 53149144329     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2008.01851.x     Document Type: Article

References (35)

1. Lane R, Baldwin D, Preskorn S. The SSRIs: Advantages, disadvantages and differences. J. Psychopharmacol. 1995 9 : 163 178.
2. Van der Kolk BA, Dreyfuss D, Michaels M et al. Fluoxetine in posttraumatic stress disorder. J. Clin. Psychiatry 1994 55 : 517 522.
3. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch. Gen. Psychiatry 1990 47 : 411 418.
4. Bymaster FP, Zhang W, Carter PA et al. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology 2002 160 : 353 361.
5. Fuller RW. Uptake inhibitor increase extracellular serotonin concentrations measured by brain microdialysis. Life Sci. 1994 55 : 163 167.
6. Invernizzi R, Belli S, Samanin R. Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res. 1992 584 : 322 324.
7. Muraki I, Inoue T, Hashimoto S, Izumi T, Ito K, Koyama T. Effects of subchronic lithium treatment on citalopram-induced increases in extracellular concentrations of serotonin in the medial prefrontal cortex. J. Neurochem. 2001 76 : 490 497.
8. 1A antagonists. Trends Neurosci. 1996 19 : 378 383.
9. Artigas F, Perez V, Alvarez E. Pindolol induces a rapid improvement of patients treated with serotonin reuptake inhibitors. Arch. Gen. Psychiatry 1994 51 : 248 251.
10. Chaput Y, de Montigny C, Blier P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 1986 333 : 342 348.
11. Invernizzi R, Bramante M, Samanin R. Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: Role of presynaptic serotonin1A receptors. Eur. J. Pharmacol. 1994 260 : 243 246.
12. Rutter JJ, Gundlah C, Auerbach SB. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptors activation. Synapse 1995 20 : 225 233.
13. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch. Pharmacol. 1995 352 : 141 148.
14. Rutter JJ, Gundlah C, Auerbach SB. Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci. Lett. 1994 171 : 183 186.
15. 1A autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635. Neuropsychopharmacology 2001 24 : 11 20.
16. Hjorth S, Auerbach SB. Autoreceptors remain functional after prolonged treatment with a serotonin reuptake inhibitor. Brain Res. 1999 835 : 224 228.
17. Gundlah C, Hjorth S, Auerbach SB. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: This effect persists after repeated citalopram treatment. Neuropharmacology 1997 36 : 475 482.
18. Invernizzi R, Bramante M, Samanin R. Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram. Brain Res. 1995 696 : 62 66.
19. 11C] DASB position emission tomography study. Am. J. Psychiatry 2004 161 : 826 835.
20. Thomas DR, Nelson DR, Johnson AM. Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor. Psychopharmacology (Berl) 1987 93 : 193 200.
21. Sánchez C, Hytell J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell. Mol. Neurobiol. 1999 19 : 467 489.
22. Trivedi MH, Rush AJ, Wisniewski SR et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. Am. J. Psychiatry 2006 163 : 28 40.
23. Arborelius L, Nomikos GG, Hertel P et al. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram. Naunyn Schmiedebergs Arch. Pharmacol. 1996 353 : 630 640.
24. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: A microdialysis study. J. Neurochem. 1993 60 : 776 779.
25. 1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur. J. Pharmacol. 1994 260 : 251 255.
26. 1A receptors in the effects of acute and chronic fluoxetine on extracellular serotonin in the frontal cortex. Pharmacol. Biochem. Behav. 1996 54 : 143 147.
27. 1A receptor antagonist and an SSRI in vivo: Effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 1995 115 : 1064 1070.
28. Ceci A, Baschirotto A, Borsini F. The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotonergic neurons in rats is attenuated by lesion of the frontal cortex. Neuropharmacology 1994 51 : 709 713.
29. Hajos M, Richards CD, Szekely AD, Sharp T. An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience 1998 87 : 95 108.
30. Bosker FJ, Cremers TIFH, Jongsma ME, Westerink BHC, Wikstrom HV, den Boer JA. Acute and chronic effects of citalopram on postsynaptic 5-hydroxytryptamine1A receptor-mediated feedback: A microdialysis study in the amygdala. J. Neurochem. 2001 76 : 1645 1653.
31. Li XB, Inoue T, Hashimoto S, Koyama T. Effect of chronic administration of flesinoxan and fluvoxamine on freezing behavior induced by conditioned fear. Eur. J. Pharmacol. 2001 425 : 43 50.
32. Hashimoto S, Inoue T, Koyama T. Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats. Psychopharmacology 1996 123 : 182 186.
33. Inoue T, Tsuchiya K, Koyama T. Serotonergic activation reduces defensive freezing in the conditioned fear paradigm. Pharmacol. Biochem. Behav. 1996 53 : 825 831.
34. Muraki I, Inoue T, Hashimoto S et al. Effect of subchronic lithium carbonate treatment on anxiolytic-like effect of citalopram and MKC-242 in conditioned fear stress in the rat. Eur. J. Pharmacol. 1999 383 : 223 229.
35. Beck P, Tanghøj P, Andersen HF et al. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression. Psychopharmacology 2002 163 : 20 25.